ID
37619
Beschrijving
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Trefwoorden
Versies (1)
- 11-08-19 11-08-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
11 augustus 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Eligibility Determination
- StudyEvent: ODM
Beschrijving
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Beschrijving
Epithelial Ovarian Cancer, FIGO stage
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0677886
- UMLS CUI [1,2]
- C0450454
Beschrijving
Prior Chemotherapy; prior radiation therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C1514457
- UMLS CUI [2]
- C0279134
Beschrijving
Age
Datatype
boolean
Alias
- UMLS CUI [1]
- C0001779
Beschrijving
ECOG performance status, Karnofsky Performance status
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1520224
- UMLS CUI [1,2]
- C0206065
Beschrijving
Life Expectancy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023671
Beschrijving
Residual Tumor
Datatype
boolean
Alias
- UMLS CUI [1]
- C0543478
Beschrijving
Hemotologic function; Renal function; Liver function
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0221130
- UMLS CUI [1,2]
- C0232804
- UMLS CUI [1,3]
- C0232741
Beschrijving
Informed Consent
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
Epithelioma; Mucinous cystic tumor of borderline malignancy
Datatype
boolean
Alias
- UMLS CUI [1]
- C1368683
- UMLS CUI [2]
- C0334365
Beschrijving
Prior Chemotherapy; prior radiation therapy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514457
- UMLS CUI [1,2]
- C0279134
Beschrijving
Residual Tumor
Datatype
boolean
Alias
- UMLS CUI [1]
- C0543478
Beschrijving
Communicable Disease; Disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C000945
- UMLS CUI [2]
- C0012634
Beschrijving
Dementia; Abnormal mental state
Datatype
boolean
Alias
- UMLS CUI [1]
- C0497327
- UMLS CUI [2]
- C0278061
Beschrijving
Experimental drug, Hypersensitivity
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0020517
Beschrijving
Other medical condition,at risk; Therapeutic procedure, at risk
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3843040
- UMLS CUI [1,2]
- C1444641
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C1444641
Beschrijving
Malignant Neoplasms
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Beschrijving
Chemotherapy, Simultaneous; Hormone therapy, Simultaneous; Therapeutic radiology procedure, Simultaneous
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3665472
- UMLS CUI [1,2]
- C0521115
- UMLS CUI [2,1]
- C0279025
- UMLS CUI [2,2]
- C0521115
- UMLS CUI [3,1]
- C1522449
- UMLS CUI [3,2]
- C0521115
Similar models
Eligibility Determination
- StudyEvent: ODM
C0450454 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2])
C0206065 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,2])
C0232741 (UMLS CUI [1,3])
C0334365 (UMLS CUI [2])
C0279134 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2])
C0278061 (UMLS CUI [2])
C0020517 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0521115 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0521115 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0521115 (UMLS CUI [3,2])